PL3615036T3 - Wytwarzanie ekstraktu 20-hydroksyekdyzonu o jakości farmaceutycznej - Google Patents

Wytwarzanie ekstraktu 20-hydroksyekdyzonu o jakości farmaceutycznej

Info

Publication number
PL3615036T3
PL3615036T3 PL18721042.2T PL18721042T PL3615036T3 PL 3615036 T3 PL3615036 T3 PL 3615036T3 PL 18721042 T PL18721042 T PL 18721042T PL 3615036 T3 PL3615036 T3 PL 3615036T3
Authority
PL
Poland
Prior art keywords
hydroxyecdysone
extract
preparation
pharmaceutical grade
grade
Prior art date
Application number
PL18721042.2T
Other languages
English (en)
Inventor
René LAFONT
Pierre Dilda
Waly Dioh
Philippe Dupont
Susanna DEL SIGNORE
Stanislas Veillet
Original Assignee
Biophytis
Sorbonne Université
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophytis, Sorbonne Université filed Critical Biophytis
Publication of PL3615036T3 publication Critical patent/PL3615036T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
PL18721042.2T 2017-04-28 2018-04-30 Wytwarzanie ekstraktu 20-hydroksyekdyzonu o jakości farmaceutycznej PL3615036T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1753775A FR3065644B1 (fr) 2017-04-28 2017-04-28 Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation
FR1758071A FR3065642B1 (fr) 2017-04-28 2017-08-31 Utilisation de 20-hydroxyecdysone et ses derives dans le traitement des myopathies
PCT/EP2018/061060 WO2018197731A1 (fr) 2017-04-28 2018-04-30 Extrait de 20-hydroxyecdysone de qualité pharmaceutique, son utilisation et sa préparation

Publications (1)

Publication Number Publication Date
PL3615036T3 true PL3615036T3 (pl) 2024-06-10

Family

ID=59381456

Family Applications (2)

Application Number Title Priority Date Filing Date
PL18719583T PL3615035T3 (pl) 2017-04-28 2018-04-27 Zastosowanie 20-hydroksyekdyzonu i jego pochodnych w leczeniu miopatii
PL18721042.2T PL3615036T3 (pl) 2017-04-28 2018-04-30 Wytwarzanie ekstraktu 20-hydroksyekdyzonu o jakości farmaceutycznej

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL18719583T PL3615035T3 (pl) 2017-04-28 2018-04-27 Zastosowanie 20-hydroksyekdyzonu i jego pochodnych w leczeniu miopatii

Country Status (12)

Country Link
US (2) US11542295B2 (pl)
EP (2) EP3615035B1 (pl)
JP (2) JP7295806B2 (pl)
KR (2) KR102652803B1 (pl)
CN (2) CN110769832B (pl)
BR (1) BR112019022392A2 (pl)
DK (1) DK3615036T3 (pl)
ES (2) ES2882571T3 (pl)
FR (2) FR3065644B1 (pl)
PL (2) PL3615035T3 (pl)
PT (2) PT3615035T (pl)
WO (2) WO2018197708A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3065644B1 (fr) * 2017-04-28 2020-02-21 Biophytis Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation
FR3078252B1 (fr) * 2018-02-28 2020-08-14 Biophytis Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation
CZ309080B6 (cs) * 2018-12-19 2022-01-19 Karel Dr. Sláma Způsob stanovení rizika vzniku maligních nádorů
FR3093640B1 (fr) 2019-03-15 2021-10-01 Biophytis Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de maladies neuromusculaires
FR3093641B1 (fr) * 2019-03-15 2023-11-03 Biophytis Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement de l’altération de la fonction respiratoire
FR3108504B1 (fr) 2020-03-30 2023-03-31 Biophytis Phytoecdysones et leurs dérivés pour leur utilisation dans le traitement d’altérations de la fonction respiratoire lors d’une infection virale
CN113208962B (zh) * 2021-05-10 2024-07-02 江苏省中国科学院植物研究所 一种鹿草提取物、制备方法及其应用
FR3143975B1 (fr) 2022-12-23 2025-10-24 Biophytis Phytoecdysones pour leur utilisation dans le traitement de pathologies respiratoires inflammatoires
FR3157102A1 (fr) 2023-12-22 2025-06-27 Biophytis Compositions de phytoecdysones pour leur administration par voie intranasale
FR3158880A1 (fr) 2024-02-01 2025-08-08 Biophytis Phytoecdysones et/ou dérivés de 20-hydroxyecdysone en combinaison avec un agoniste de GLP-1 pour leur utilisation dans le traitement de l’obésité et du surpoids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38540A0 (en) * 1971-01-18 1972-03-28 Dauten Sa Method for the extraction of insect moulting steroid hormones
CN1353113A (zh) 2001-11-29 2002-06-12 沈阳药科大学 中药牛膝有效部位及其制剂与医药用途和制备方法
WO2011127398A2 (en) * 2010-04-08 2011-10-13 The Arizona Board Of Regents On Behalf Of The University Of Arizona In vitro cellular bioassay for neurotoxicity testing
FR3021318B1 (fr) * 2014-05-20 2017-04-28 Inst Biophytis Produits derives de la 20-hydroxyecdysone et leur utilisation dans la preparation de medicaments
US9700589B2 (en) * 2015-02-03 2017-07-11 Naturex Sa Compositions and methods for improved muscle metabolism
FR3065644B1 (fr) * 2017-04-28 2020-02-21 Biophytis Extrait de 20-hydroxyecdysone de qualite pharmaceutique, son utilisation et sa preparation

Also Published As

Publication number Publication date
BR112019022392A2 (pt) 2020-05-19
ES2971226T3 (es) 2024-06-04
FR3065642A1 (fr) 2018-11-02
FR3065642B1 (fr) 2020-02-28
EP3615035B1 (fr) 2021-06-09
EP3615036A1 (fr) 2020-03-04
BR112019022379A2 (pt) 2020-05-19
US20200148718A1 (en) 2020-05-14
US11542295B2 (en) 2023-01-03
EP3615035A1 (fr) 2020-03-04
JP2020517712A (ja) 2020-06-18
KR20200005574A (ko) 2020-01-15
PT3615035T (pt) 2021-08-20
FR3065644B1 (fr) 2020-02-21
CN110753547A (zh) 2020-02-04
PT3615036T (pt) 2024-02-27
WO2018197708A1 (fr) 2018-11-01
KR102652803B1 (ko) 2024-04-01
WO2018197731A1 (fr) 2018-11-01
EP3615036B1 (fr) 2023-11-22
CN110753547B (zh) 2024-05-14
ES2882571T3 (es) 2021-12-02
CN110769832A (zh) 2020-02-07
CN110769832B (zh) 2023-08-01
JP2020517697A (ja) 2020-06-18
DK3615036T3 (da) 2024-02-12
FR3065644A1 (fr) 2018-11-02
JP7165143B2 (ja) 2022-11-02
US20200179407A1 (en) 2020-06-11
KR102593901B1 (ko) 2023-10-26
PL3615035T3 (pl) 2021-12-20
KR20200012871A (ko) 2020-02-05
JP7295806B2 (ja) 2023-06-21

Similar Documents

Publication Publication Date Title
PL3615036T3 (pl) Wytwarzanie ekstraktu 20-hydroksyekdyzonu o jakości farmaceutycznej
IL261989A (en) A pharmaceutical preparation of flavociclib and a method for its preparation
SG11201702298VA (en) Pharmaceutical preparation
ZA201908454B (en) Solid preparation of cariprazine for oral administration
IL271226A (en) medical preparation
SG11202004615YA (en) A type of organic nanogrids and their nanopolymers as well as their preparation methods
GB201703876D0 (en) Pharmaceutical combinations
IL259007A (en) Anti-aging preparations
EP3247996A4 (en) Quantification and preparation of pharmaceutical grade cantharidin
LT3223796T (lt) Farmacinės kompozicijos, jų gamyba ir panaudojimo būdai
EP3275451A4 (en) Chinese medicine extract and preparation method and application thereof
PL3313370T3 (pl) Okulistyczna kompozycja farmaceutyczna
IL267279A (en) Pharmaceutical formulations of suvorexant
IL266938A (en) Pharmaceutical preparation and method for its production
EP3247374A4 (en) Compositions containing a spiranthes sinensis extract and pharmaceutical applications thereof
EP3110403A4 (en) Taste masking drug formulations
PT3601277T (pt) Formulação farmacêutica
IL275144A (en) Pharmacy preparation
IL271908A (en) Over-compressed pharmaceutical preparations
ZA202006346B (en) Pharmaceutical preparation
IL273904A (en) Medicinal resin components and methods for their production and use
GB201706836D0 (en) Beverage preparation capsules
PL3398587T3 (pl) Skompaktowany preparat farmaceutyczny
HU1600240V0 (hu) Alapanyagokat tartalmazó kapszula italok elõállításához
GB201719873D0 (en) Pharmaceutical formulation